• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals


1,118.65 INR 11.25 1.00%

As of 07:06:05 ET on 07/28/2014.

Snapshot for Lupin Ltd (LPC)

Open: 1,129.90 Day's Range: 1,110.20 - 1,139.00 Volume: 360,579
Previous Close: 1,129.90 52wk Range: 742.30 - 1,139.00 1-Yr Rtn: +31.50%

Stock Chart for LPC

No chart data available.
  • LPC:IN 1,118.65
  • 1D
  • 1M
  • 1Y
Interactive LPC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LPC

Current P/E Ratio (ttm) 27.2908
Estimated P/E(03/2015) 23.3271
Relative P/E vs. SENSEX 1.4828
Earnings Per Share (INR) (ttm) 40.9900
Est. EPS (INR) (03/2015) 47.9550
Est. PEG Ratio 1.4085
Market Cap (M INR) 501,773.57
Shares Outstanding (M) 448.55
30 Day Average Volume 502,147
Price/Book (mrq) 7.2361
Price/Sale (ttm) 4.4401
Dividend Indicated Gross Yield 0.27%
Cash Dividend (INR) 3.0000
Dividend Ex-Date 07/21/2014
5 Year Dividend Growth 19.14%
Next Earnings Announcement 07/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LPC

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for LPC

Lupin Limited manufactures bulk actives and formulations. The principal bulk actives manufactured by it include Rifampicin, Pyrazinamide, Ethambutol (anti-TB), Cephalosporins (anti-infectives) and cardiovasculars. The company also possesses competencies in phytomedicines, in which medicines are made out of plant and herbal resources supported by the discipline of modern medicine.

Desh Bandhu GuptaChairman/FounderKamal Kishore SharmaVice Chairman
Vinita GuptaChief Executive OfficerNilesh D GuptaManaging Director
More Company Profile & Key Executives for LPC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil